Abstract: A method for detecting a faulty cooling unit in a set of cooling units configured to provide a coolant to work rolls arranged to process a work item therebetween, the method including: varying the flow rates of the coolant ejected from a sub-set of the cooling units; in response to varying the flow rates, determining a flatness variation value of the work item for at least each of the cooling units in the sub-set of cooling units, the flatness variation value being indicative of the work item flatness variation downstream of the work rolls; and detecting a faulty cooling unit based on comparing the flatness variation values to a reference flatness variation value.

Abstract: A method for detecting a faulty cooling unit in a set of cooling units configured to provide a coolant to work rolls arranged to process a work item therebetween, the method including: varying the flow rates of the coolant ejected from a sub-set of the cooling units; in response to varying the flow rates, determining a flatness variation value of the work item for at least each of the cooling units in the sub-set of cooling units, the flatness variation value being indicative of the work item flatness variation downstream of the work rolls; and detecting a faulty cooling unit based on comparing the flatness variation values to a reference flatness variation value.

Abstract: A method of controlling flatness of a strip of rolled material in a production line including a hot rolling mill and at least one cold rolling mill, downstream of the hot rolling mill, the method including determining flatness data of the strip in one or more of the at least one cold rolling mill and/or following passing of the strip through one or more of the at least one cold rolling mill; determining a thickness profile target of the strip for the hot rolling mill based on the flatness data; and passing the strip through the hot rolling mill and adjusting the thickness of the strip based on the thickness profile target. A control system and a production line are also provided.

Abstract: The present invention relates to a unit dosage composition in the form of a film or a water containing from 0.25 mg to 2 mg of midazolam or a pharmaceutically acceptable salt thereof, and a film-forming substance.

Abstract: The present invention relates to a unit dosage composition in the form of a film or a water containing from 0.25 mg to 2 mg of midazolam or a pharmaceutically acceptable salt thereof, and a film-forming substance.

Abstract: The invention relates to the use of one or more oligomers of lactic acid or a lactic acid oligomeric product for the prophylaxis and/or treatment of a disease or condition that benefits from an acidic environment, especially a gynaecological infection including a bacterial infection such as bacterial vaginosis, unspecific colpitis, senile colpitis, cervicitis, and urethritis, a fungal infection, such as candidosis (Candida albicans), cryptococcosis, actinomycosis, or a viral infection, such as Human Immunodefiency Virus (HIV), Herpes Simplex Virus (HSV), Human Papilloma Virus (HPV).

Abstract: The invention relates to the use of one or more oligomers of lactic acid or a lactic acid oligomeric product for the prophylaxis and/or treatment of a disease or condition that benefits from an acidic environment, especially a gynaecological infection including a bacterial infection such as bacterial vaginosis, unspecific colpitis, senile colpitis, cervicitis, and urethritis, a fungal infection, such as candidosis (Candida albicans), cryptococcosis, actinomycosis, or a viral infection, such as Human Immunodefiency Virus (HIV), Herpes Simplex Virus (HSV), Human Papilloma Virus (HPV).

Abstract: The invention relates to an oligomeric lactic acid composition comprising one or more oligomers of lactic acid or a pharmaceutical composition comprising an oligomeric lactic acid composition for the prophylaxis and/or treatment of a disease or condition that benefits from an acidic environment.

Abstract: The invention relates to the use of one or more oligomers of lactic acid or a lactic acid oligomeric product for the prophylaxis and/or treatment of a disease or condition that benefits from an acidic environment, especially a gynaecological infection including a bacterial infection such as bacterial vaginosis, unspecific colpitis, senile colpitis, cervicitis, and urethritis, a fungal infection, such as candidosis (Candida albicans), cryptococcosis, actinomycosis, or a viral infection, such as Human Immunodefiency Virus (HIV), Herpes Simplex Virus (HSV), Human Papilloma Virus (HPV).

Abstract: Use of the one or more oligomers of lactic acid with the following formula (I) wherein n is an integer from 2 to 25 such as, e.g., from 2 to 20, from 3 to 25, from 3 to 20, from 2 to 15, from 3 to 15, from 2 to 10, from 3 to 10, from 4 to 10, or from 4 to 9 or a lactic acid oligomeric product for the prophylaxis and/or treatment of a disease or condition that benefit of an acidic environment especially a gynaecological infection such as a bacterial infection, such as bacterial vaginosis, unspecific colpitis, senile colpitis, cervicitis, and urethritis, a fungal infection, such as candidosis (Candida albicans), cryptococcosis, actinomycosis, or a viral infection, such as Human Immunodefiency Virus (HIV), Herpes Simplex Virus (HSV), Human Papilloma Virus (HPV).